TORONTO, ONTARIO–(Marketwired – Feb. 24, 2017) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical-stage immuno-oncology company developing innovative therapies for [...]
MONTREAL, QUEBEC–(Marketwired – Feb. 24, 2017) – Theratechnologies Inc. (TSX:TH) (Theratechnologies) announced today that it will host an Investment Community […]
TORONTO, ONTARIO–(Marketwired – Feb. 24, 2017) – Buffalo Coal Corp. (TSX VENTURE:BUF)(JSE:BUC) (“Buffalo” or “the Company”) announced today that it […]